Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 study
Buse JB et al. Diabetes Care 2018. doi: 10.2337/dc18-0343
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.